Skip Navigation

Profile

Carlos M. Ferrario, M.D.Wake Forest School of Medicine

Carlos M. Ferrario, M.D.

Professor,


Contact Information

Academic: 336-716-5849 | Department: 336-716-5849

Email: cferrari@wakehealth.edu

Additional Languages

Italian, Spanish

Education & Training

  • B.A., Mariano Moreno College-Argentina, 1956
  • M.D., Univ Buenos Aires Faculty of Med-Argentina, 1963
  • Internship, Italian Hospital Buenos Aires-, 1963
  • Residency, Italian Hospital Buenos Aires-, 1965
  • Fellowship, Univ Goteborg Med Fac-Sweden, 1965
  • Fellowship, Karolinska Institute-Sweden, 1966
  • Fellowship, Cleveland Clinic Foundation, 1969

Memberships

  • Int'L Society Of Angiology
  • Int'L Society Of Hypertension
  • Int'L Society On Hypertension
  • Nat'L Heart Lung & Blood Inst
  • Am Heart Association
  • Am Physiological Society
  • Assn Of Black Cardiologists
Carlos M. Ferrario, M.D.

Carlos M. Ferrario, M.D.

Professor, Surgery, General
Office of Women in Medicine and Science
Physiology & Pharmacology

Research Interests

Hypertension; Peptide Fragments; Renin-Angiotensin System; Angiotensin II; Angiotensin I
More »

Contact Information

Academic: 336-716-5849 | Department: 336-716-5849

Email: cferrari@wakehealth.edu

Recent Publications

Effect of age, estrogen status, and late-life GPER activation on cardiac structure and function in the Fischer344xBrown Norway female rat. Alencar AK, da Silva JS, Lin M, Silva AM, Sun X, Ferrario CM, Cheng C, Sudo RT, Zapata-Sudo G, Wang H, Groban L.. J Gerontol A Biol Sci Med Sci. 2017;72(2):152-162.

Cardiomyocyte-specific deletion of the G protein-coupled estrogen receptor (GPER) leads to left ventricular dysfunction and adverse remodeling: a sex-specific gene profiling analysis. Wang H, Sun X, Chou J, Lin M, Ferrario CM, Zapata-Sudo G, Groban L.. Biochim Biophys Acta. 2017;1863(8):1870-1882.

Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure. Zhang X, Cheng HJ, Zhou P, Kitzman DW, Ferrario CM, Li WM, Cheng CP.. Int J Cardiol. 2017;236():405-412.

Novel cardiac intracrine mechanisms based on Ang-(1-12)/chymase axis require a revision of therapeutic approaches in human heart disease. Reyes S, Varagic J, Ahmad S, VonCannon J, Kon ND, Wang H, Groban L, Cheng CP, Dell'Italia LJ, Ferrario CM.. Curr Hypertens Rep. 2017;19(2):16.

Walmor C. De Mello: "your heart is still with us" [in memoriam]. Ferrario CM, Frohlich ED, Gerena Y.. Hypertension. 2017;69(6):992-993.

Role of tissue renin-angiotensin system and the chymase/angiotensin-(1-12) axis in the pathogenesis of diabetic retinopathy. Ola MS, Alhomida AS, Ferrario CM, Ahmad S.. Curr Med Chem. 2017;():.

Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. Ferrario CM, Mullick AE.. Pharmacol Res. 2017;():.

Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2. da Silva JS, Gabriel-Costa D, Wang H, Ahmad S, Sun X, Varagic J, Sudo RT, Ferrario CM, Dell Italia LJ, Sudo GZ, Groban L.. J Renin Angiotensin Aldosterone Syst. 2017;18(3):.

Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload. Fu L, Wei CC, Powell PC, Bradley WE, Ahmad S, Ferrario CM, Collawn JF, Dell'Italia LJ.. J Mol Cell Cardiol. 2016;92():1-9.

Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene. Ferrario CM, VonCannon JL, Jiao Y, Ahmad S, Bader M, Dell'Italia LJ, Groban L, Varagic J.. Am J Physiol Heart Circ Physiol. 2016;310(8):H995-H1002.

Mast cell inhibition attenuates cardiac remodeling and diastolic dysfunction in middle-aged, ovariectomized Fischer 344 x Brown Norway rats. Wang H, da Silva J, Alencar A, Zapata-Sudo G, Lin MS, Sun X, Ahmad S, Ferrario CM, Groban L.. J Cardiovasc Pharmacol. 2016;68(1):49-57.

Cardiac remodelling and RAS inhibition. Ferrario CM.. Ther Adv Cardiovasc Dis. 2016;10(3):162-171.

Intracrine angiotensin II functions originate from noncanonical pathways in the human heart. Ferrario CM, Ahmad S, Varagic J, Cheng CP, Groban L, Wang H, Collawn JF, Dell'Italia LJ.. Am J Physiol Heart Circ Physiol. 2016;311(2):H404-H414.

Preface [editorial]. Ferrario CM, Wang JG.. Ther Adv Cardiovasc Dis. 2016;10(3):116-117.

Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme. Ahmad S, Varagic J, VonCannon JL, Groban L, Collawn JF, Dell'Italia LJ, Ferrario CM.. Biochem Biophys Res Commun. 2016;478(2):559-564.

Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle. De Mello WC, Dell'Itallia LJ, Varagic J, Ferrario CM.. Mol Cell Biochem. 2016;422(1-2):31-40.

Inflammatory and mitochondrial gene expression data in GPER-deficient cardiomyocytes from male and female mice. Wang H, Sun X, Chou J, Lin M, Ferrario CM, Zapata-Sudo G, Groban L.. Data Brief. 2016;10():465-473.

Chronic GPER activation attenuates cardiac dysfunction in a male mouse model of progressive heart failure: insights into cellular mechanisms [abstract]. Zhang X, Li T, Wang H, Cheng H-J, Li W, Ferrario CM, Groban L, Cheng C-P.. Circulation. 2016;134(Suppl 1):A12559.

Altered cardiomyocyte inotropic response to chymase/Ang-(1-12) pathway activation in heart failure [abstract]. Li T, Zhang X, Ahmad S, Varagic J, Cheng H-J, Zhang Z, Groban L, Ferrario CM, Cheng C-P.. Circulation. 2016;134(Suppl 1):A12206.

Chymase/Angiotensin I axis: a pathway for Angiotensin II generation in diabetic human vitreous [abstract]. Rubino SM, Nae AM, John V, Ahmad S, Ola MS, Ferrario CM, Greven C.. Invest Ophthalmol Vis Sci. 2016;57(12):5431.

Role of mineralocorticoid receptor antagonists in cardiovascular disease. Ferrario CM, Schiffrin EL.. Circ Res. 2015;116(1):206-213.

Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure. Zhou P, Cheng CP, Li T, Ferrario CM, Cheng HJ.. Ther Adv Cardiovasc Dis. 2015;9(6):342-353.

Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue. Nagata S, Varagic J, Kon ND, Wang H, Groban L, Simington SW, Ahmad S, Dell'Italia LJ, VonCannon JL, Deal D, Ferrario CM.. Ther Adv Cardiovasc Dis. 2015;9(4):168-180.

Renin-angiotensin-aldosterone system gender differences in an Afro-Caribbean population. Cohall DH, Scantlebury-Manning T, James S, Hall K, Ferrario CM.. J Renin Angiotensin Aldosterone Syst. 2015;16(3):539-546.

Functional significance of the chymase/ang-(1-12) pathway on cardiomyocytes [abstract]. Zhang X, Li T, Ahmad S, Varagic J, Groban L, Dell'Italia LJ, Cheng C-P, Ferrario CM.. Hypertension. 2015;66(Suppl 1):A078.

ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury. Varagic J, Ahmad S, Nagata S, Ferrario CM.. Curr Hypertens Rep. 2014;16(3):420.

Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate. Ahmad S, Varagic J, Groban L, Dell'italia LJ, Nagata S, Kon ND, Ferrario CM.. Curr Hypertens Rep. 2014;16(5):429.

Self-reported cardiovascular disease risk factors and associated hopelessness in African American participants of a church-placed health screening program. Joyner J, Cline DM, Simmons DR, Ferrario CM, Mount DL.. Ethn Dis. 2014;24(1):60-66.

An evolving story of angiotensin-II-forming pathways in rodents and humans. Ferrario CM, Ahmad S, Nagata S, Simington SW, Varagic J, Kon N, Dell'italia LJ.. Clin Sci. 2014;126(7-8):461-469.

Salt loading promotes kidney injury via fibrosis in young female Ren2 rats. Habibi J, Hayden MR, Ferrario CM, Sowers JR, Whaley-Connell AT.. Cardiorenal Med. 2014;4(1):43-52.

Chymase mediates injury and mitochondrial damage in cardiomyocytes during acute ischemia/reperfusion in the dog. Zheng J, Wei CC, Hase N, Shi K, Killingsworth CR, Litovsky SH, Powell PC, Kobayashi T, Ferrario CM, Rab A, Aban I, Collawn JF, Dell'Italia LJ.. PLoS One. 2014;9(4):e94732.

Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction. Flores-Monroy J, Ferrario CM, Valencia-Hernandez I, Hernandez-Campos ME, Martinez-Aguilar L.. Pharmacology. 2014;94(1-2):21-28.

Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction. Schindler C, Guenther K, Hermann C, Ferrario CM, Schroeder C, Haufe S, Jordan J, Kirch W.. PLoS One. 2014;9(9):e103909.

Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan. Varagic J, Punzi H, Ferrario CM.. Integr Blood Press Control. 2014;7():61-70.

Human Ang-(1-12) and hemodynamic and cardiac biometrics in rats overexpressing human angiotensinogen [abstract]. Varagic J, VonCannon JL, Nagata S, Ahmad S, Ferrario CM.. Hypertension. 2014;64(Suppl 1):A477.

Chymase-mediated angiotensin II formation in the heart of rats overexpressing the human angiotensinogen gene [abstract]. Ahmad S, VonCannon JL, Bader M, Delbruck M, Varagic J, Ferrario CM.. Hypertension. 2014;64(Suppl 1):A621.

Angiotensin-(1-12) is a better substrate compared to angiotensin I to generate angiotensin Ii by rat chymase [abstract]. Ahmad S, Varagic J, VonCannon JL, Dell'Italia LJ, Groban L, Ferrario CM.. Hypertension. 2014;64(Suppl 1):A622.

Hemodynamic and hormonal changes to dual Renin-Angiotensin system inhibition in experimental hypertension. Moniwa N, Varagic J, Ahmad S, Voncannon JL, Simington SW, Wang H, Groban L, Brosnihan KB, Nagata S, Kato J, Kitamura K, Gomez RA, Lopez ML, Ferrario CM.. Hypertension. 2013;61(2):417-424.

Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats. Varagic J, Ahmad S, VonCannon JL, Moniwa N, Brosnihan KB, Wysocki J, Batlle D, Ferrario CM.. Am J Hypertens. 2013;26(5):583-590.

Chymase mediates angiotensin-(1-12) metabolism in normal human hearts. Ahmad S, Wei CC, Tallaj J, Dell'Italia LJ, Moniwa N, Varagic J, Ferrario CM.. J Am Soc Hypertens. 2013;7(2):128-136.

Louisiana cardiometabolic risk factor disparities provide opportunities for improvement [abstract]. Joyner J, Simmons DR, Moore MA, Ferrario CM, Forrest B, Carmouche D.. In: Abstracts of the Xavier University of Louisiana College of Pharmacy Sixth Health Disparities Conference; 2013 Mar 7-9; New Orleans (LA). 2013;():46.

The never-ending story of angiotensin peptides: beyond angiotensin I and II [editorial]. Dell'Italia LJ, Ferrario CM.. Circ Res. 2013;112(8):1086-1087.

Renin inhibition and AT1R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling. Whaley-Connell A, Habibi J, Rehmer N, Ardhanari S, Hayden MR, Pulakat L, Krueger C, Ferrario CM, DeMarco VG, Sowers JR.. Metabolism. 2013;62(6):861-872.

The COSEHC Global Vascular Risk Management quality improvement program: first follow-up report. Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann W Jr, Frech-Tamas F.. Vasc Health Risk Manag. 2013;9():391-400.

Clinical and economic outcomes associated with amlodipine/renin-angiotensin system blocker combinations. Ferrario CM, Panjabi S, Buzinec P, Swindle JP.. Ther Adv Cardiovasc Dis. 2013;7(1):27-39.

Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats. Wang H, Jessup JA, Zhao Z, Da Silva J, Lin M, Macnamara LM, Ahmad S, Chappell MC, Ferrario CM, Groban L.. PLoS One. 2013;8(10):e76992.

Hemodynamic and hormonal patterns of untreated essential hypertension in men and women. Ferrario CM, Jessup JA, Smith RD.. Ther Adv Cardiovasc Dis. 2013;7(6):293-305.

Estrogen replacement downregulates cardiac angiotensin II in an ACE-independent manner in oophorectomized mRen2.Lewis rats [abstract]. Groban L, Wang H, Zhao Z, Jessup J, Lin M, MacNamara L, Ferrario CM.. In: Abstracts of the 2013 Annual Meeting of the American Society of Anesthesiologists (ASA); 2013 Oct 12-16; San Francisco (CA). 2013;():A5002.

Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats. Whaley-Connell AT, Habibi J, Aroor A, Ma L, Hayden MR, Ferrario CM, Demarco VG, Sowers JR.. Metabolism. 2013;62(12):1761-1771.

Estrogen replacement downregulates cardiac angiotensin II in an ACE-independent manner in oophorectomized mRen2.Lewis rats [abstract]. Wang H, Zhao Z, Jessup J, Lin M, MacNamara L, Ahmad S, Ferrario C, Groban L.. Circ Res. 2013;113(4 Suppl):A086.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgery, General

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.